Status:
UNKNOWN
Transcutaneous Direct Current Stimulation of the Spinal Cord for Treatment of Spasticity in Multiple Sclerosis
Lead Sponsor:
Lebanese American University
Conditions:
Spastic Parapareses
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current research is aimed at using Transcutaneous Spinal Direct Current Stimulation (tSDCS) as complementary therapeutic tool in the treatment of spasticity in multiple sclerosis. Patients will be...
Detailed Description
Spasticity is experienced in around 80 % of patients with multiple sclerosis resulting in quality of life impairment. Transcranial direct current stimulation has been proven effective for the treatmen...
Eligibility Criteria
Inclusion
- Patients diagnosed with Multiple Sclerosis according to the 2010 Mc Donald criteria with spasticity in the lower extremities
Exclusion
- Cardiac pacemakers
- Patients with prior exposure to tDCS
- Metallic hardware in the spine
- Eczema or skin abrasion at the intended site of stimulation
- Currently pregnant or plan for pregnancy in the next 6 months
- Heart or respiratory failure resulting in activity impairment
- Walking impairment due to orthopaedics condition such as deformity or recent fracture.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04287244
Start Date
March 1 2020
End Date
May 1 2022
Last Update
March 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.